The AcuTemp Plus Series of packaging solutions has been designed with patented, high-performance ThermoCor Vacuum Insulated Panels (VIP) to guarantee precise end-to-end control of internal payload temperatures.
The innovative range has been developed with simplicity in mind, benefiting from optimised system components and design. The new series is available in multiple size configurations and temperature profiles, along with different integrated track and trace options to meet specific customer needs. Further, the AcuTemp Plus Series is supported with a fully managed, end-to-end service infrastructure leveraging CSafe’s industry-unique retest and reuse programme, REPAQ.
“We are proud to expand our cold chain packaging offerings for the Cell and Gene Therapy market, and have focused and invested significantly in R&D to develop best-in-class solutions to meet the demanding product requirements for this emerging class of medication,” CEO of CSafe Global Patrick Schafer commented. “Test results of the new AcuTemp Plus Series have been very impressive with temperature performances outlasting other market available solutions by a large margin.”